Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19. Read the Press Release. Press Release from Lily Lilly Bamlanivimab Antibody Playbook News Category Featured News News Post Date Fri, 01/15/2021 - 05:05